Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-045327
Filing Date
2025-03-26
Accepted
2025-03-26 16:40:05
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-03-26

Document Format Files

Seq Description Document Type Size
1 ARS ars_2024_10k_def_14a_202.pdf ARS 885523
  Complete submission text file 0000950170-25-045327.txt   1221060
Mailing Address 10202 5TH AVENUE NE SUITE 200 SEATTLE WA 98125
Business Address 10202 5TH AVENUE NE SUITE 200 SEATTLE WA 98125 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35610 | Film No.: 25773835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)